- $26.69bn
- $22.12bn
- $1.94bn
Media: FDA plans rare advisory hearing to debate Moderna's flu shot - Bloomberg News
Factbox: Hantavirus vaccines and treatments under development
U.S. RESEARCH ROUNDUP- CAVA Group, Eagle Materials, Vertiv Holdings
US states reject anti-vaccine bills as public health groups fight MAHA
Brief: Coatue Management Cuts Share Stake In Meta, Nvidia, Microsoft
Replimune, uniQure rise; FDA commissioner Makary plans to resign
U.S. STOCKS ON THE MOVE-Barrick Mining, Lumentum, Tesla
Moderna climbs for second straight session
U.S. STOCKS ON THE MOVE-Moderna, Beazer Homes, Lumentum
Moderna climbs for second straight session
Moderna set to climb for second straight session
U.S. STOCKS ON THE MOVE-Corning, BILL Holdings, Moderna
Moderna rises, poised for biggest daily gain in over three years
Moderna rises to nearly one-month high
U.S. STOCKS ON THE MOVE-Krispy Kreme, Tesla, Axon Enterprise
U.S. STOCKS ON THE MOVE-Albemarle, Howmet, Travere Therapeutics
Moderna rises, study shows its mRNA flu vaccine outperforms standard shot
Moderna rises, study shows its mRNA flu vaccine outperforms standard shot
Moderna's mRNA flu vaccine outperforms standard shot in late-stage trial